These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2675102)

  • 1. Cyclosporine in children.
    Polchi P; Lucarelli G; Galimberti M; Moretti L
    Prog Clin Biol Res; 1989; 309():333-48. PubMed ID: 2675102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclosporine in allogeneic bone marrow transplantation in children].
    Kojima S; Fukuda M; Horibe K; Matsuyama K
    Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of graft rejection after bone marrow transplant in thalassemia.
    Galimberti M; Andreani M; Lucarelli G; Centis F; Filocamo M; Polchi P; Manenti F; Agostinelli F; Giorgi C; Filippetti A
    Prog Clin Biol Res; 1989; 309():223-9. PubMed ID: 2675090
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation in thalassemia. The experience of Pesaro.
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Manenti F; Politi P; Durazzi SM; Albertini F
    Prog Clin Biol Res; 1989; 309():163-71. PubMed ID: 2675083
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
    Tollemar J; Ringdén O; Heimdahl A; Lönnqvist B; Sundberg B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):470-9. PubMed ID: 3291283
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
    Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A
    Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine and graft-versus-host disease after bone marrow transplantation.
    N Engl J Med; 1988 Dec; 319(24):1607-8. PubMed ID: 3059188
    [No Abstract]   [Full Text] [Related]  

  • 9. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
    Britton K; Atkinson K; Downs K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease.
    Slavin S; Or R; Cividalli G; Brautbar C; Hale G; Waldmann H; Rachmilewitz E
    Birth Defects Orig Artic Ser; 1988; 23(5B):313-6. PubMed ID: 3291967
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination prophylactic immunosuppression in bone marrow transplantation.
    Szer J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3011-2. PubMed ID: 2650415
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation in class 2 thalassemia patients.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Baronciani D; Angelucci E
    Bone Marrow Transplant; 1993; 12 Suppl 1():59-62. PubMed ID: 8374566
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E; Devergie A; Lokiec F
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract]   [Full Text] [Related]  

  • 15. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids.
    Ruutu T; Volin L; Elonen E
    Transplant Proc; 1988 Jun; 20(3):491-3. PubMed ID: 3289191
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cyclosporin A].
    Gabrielli A; Rupoli S
    Recenti Prog Med; 1985 Jun; 76(6):326-31. PubMed ID: 3903888
    [No Abstract]   [Full Text] [Related]  

  • 18. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
    Erer B; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Galimberti M; Giardini C; Gaziev D; Maiello A
    Bone Marrow Transplant; 1996 Jul; 18(1):157-62. PubMed ID: 8832009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
    Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation for thalassemia in Pescara.
    Di Bartolomeo P; Di Girolamo G; Angrilli F; Catinella V; Ciancarelli M; Dragani A; D'Antonio D; Palka G; Guanciali-Franchi P; Iacone A
    Prog Clin Biol Res; 1989; 309():193-9. PubMed ID: 2675086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.